A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression

Psychopharmacology

Volumn 231, Issue 5, 2014, Pages 939-948

  Hantsoo, Liisa ^a,b   Ward O'Brien, Deborah ^c   Czarkowski, Kathryn A ^a,b   Gueorguieva, Ralitza ^c,d   Price, Lawrence H ^e   Epperson, C Neill ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Penn Center for the Study of Sex and Gender in Behavioral Health   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

Depression; Postpartum; Pregnancy; Puerperal; Sertraline; SSRI; Women

Indexed keywords

PLACEBO; SERTRALINE; ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; EDINBURGH POSTNATAL DEPRESSION SCALE; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HEADACHE; HUMAN; NAUSEA; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RANDOMIZED CONTROLLED TRIAL; REMISSION; DEPRESSION, POSTPARTUM;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSION, POSTPARTUM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; PLACEBOS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 84896718249     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3316-1     Document Type: Article

References (42)

1. Amin Z, Canli T, Epperson CN (2005) Effect of estrogen-serotonin interactions on mood and cognition. Behav Cogn Neurosci Rev 4:43-58. doi: 10.1177/1534582305277152
2. APA (2000) Diagnostic and statistical manual of mental disorders (4th ed., text revision). American Psychological Association, Washington, DC
3. Appleby L, Warner R, Whitton A, Faragher B (1997) A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ 314:932-936
4. Bloch M, Meiboom H, Lorberblatt M et al (2012) The effect of sertraline add-on to brief dynamic psychotherapy for the treatment of postpartum depression: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 73:235-241. doi: 10.4088/JCP.11m07117
5. Cooper PJ, Murray L (1995) Course and recurrence of postnatal depression. Evidence for the specificity of the diagnostic concept. Br J Psychiatry 166:191-195
6. Cox JL, Holden JM, Sagovsky R (1987) Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150:782-786
7. Davanzo R, Copertino M, De Cunto A et al (2011) Antidepressant drugs and breastfeeding: a review of the literature. Breastfeed Med 6:89-98. doi: 10.1089/bfm.2010.0019
8. DeVane CL, Liston HL, Markowitz JS (2002) Clinical pharmacokinetics of sertraline. Clin Pharmacokinet 41:1247-1266
9. Epperson C, Anderson GM, McDougle CJ (1997) Sertraline and breast-feeding. N Engl J Med 336:1189-1190. doi: 10.1056/NEJM199704173361615
10. Epperson C, Czarkowski KA, Ward-O'Brien D et al (2001) Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am J Psychiatry 158:1631-1637
11. Epperson C, Jatlow PI, Czarkowski K, Anderson GM (2003) Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs. Pediatrics 112:e425-e425. doi: 10.1542/peds.112.5.e425
12. First MB, Spitzer RL, Gibbon M, Williams JBW (1995) Structured clinical interview for DSM-IV Axis I Disorders, patient edition (SCID-I/P v 2.0). Biometrics Research, New York State Psychiatric Institute, New York
13. Gavin NI, Gaynes BN, Lohr KN et al (2005) Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 106:1071-1083. doi: 10.1097/01.AOG.0000183597.31630.db
14. Griffin LD, Mellon SH (1999) Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci U S A 96:13512-13517
15. Guy W (1976) ECDEU assessment manual for psychopharmacology. US Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration, Rockville, MD
16. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32(1):50-55
17. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatr 23:56-62
18. Hübner-Liebermann B, Hausner H, Wittmann M (2012) Recognizing and treating peripartum depression. Dtsch Arztebl Int 109:419-424. doi: 10.3238/arztebl.2012.0419
19. Kaplan PS, Danko CM, Kalinka CJ, Cejka AM (2012) A developmental decline in the learning-promoting effects of infant-directed speech for infants of mothers with chronically elevated symptoms of depression. Infant Behav Dev 35:369-379. doi: 10.1016/j.infbeh.2012.02.009
20. Kennedy SH, Andersen HF, Thase ME (2009) Escitalopram in the treatment of major depressive disorder: a meta-analysis. Curr Med Res Opin 25:161-175. doi: 10.1185/03007990802622726
21. Logsdon MC, Wisner K, Hanusa BH, Phillips A (2003) Role functioning and symptom remission in women with postpartum depression after antidepressant treatment. Arch Psychiatr Nurs 17:276-283
22. Luisi S, Petraglia F, Benedetto C et al (2000) Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J Clin Endocrinol Metab 85:2429-2433
23. Misri S, Abizadeh J, Albert G et al (2012) Restoration of functionality in postpartum depressed mothers: an open-label study with escitalopram. J Clin Psychopharmacol 32:729-732. doi: 10.1097/JCP.0b013e31826867c9
24. Misri S, Kendrick K, Oberlander TF et al (2010) Antenatal depression and anxiety affect postpartum parenting stress: a longitudinal, prospective study. Can J Psychiatry 55:222-228
25. Misri S, Reebye P, Corral M, Milis L (2004) The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry 65:1236-1241
26. Murray L, Hipwell A, Hooper R et al (1996) The cognitive development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry 37:927-935
27. Nonacs RM, Soares CN, Viguera AC et al (2005) Bupropion SR for the treatment of postpartum depression: a pilot study. Int J Neuropsychopharmacol 8:445-449. doi: 10.1017/S1461145705005079
28. Paul IM, Downs DS, Schaefer EW et al (2013) Postpartum anxiety and maternal-infant health outcomes. Pediatrics 131:e1218-1224. doi: 10.1542/peds.2012-2147
29. Philipps LH, O'Hara MW (1991) Prospective study of postpartum depression: 4 1/2-year 0follow-up of women and children. J Abnorm Psychol 100:151-155
30. Reck C, Hunt A, Fuchs T et al (2004) Interactive regulation of affect in postpartum depressed mothers and their infants: an overview. Psychopathology 37:272-280. doi: 10.1159/000081983
31. Reck C, Noe D, Gerstenlauer J, Stehle E (2012) Effects of postpartum anxiety disorders and depression on maternal self-confidence. Infant Behav Dev 35:264-272. doi: 10.1016/j.infbeh.2011.12.005
32. Shanmugan S, Epperson CN (2012) Estrogen and the prefrontal cortex: towards a new understanding of estrogen's effects on executive functions in the menopause transition. Hum Brain Mapp. doi: 10.1002/hbm.22218
33. Sharp DJ, Chew-Graham C, Tylee A, et al. (2010) A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial. Health Technol Assess 14:iii-iv, ix-xi, 1-153. doi: 10.3310/hta14430
34. Sockol LE, Epperson CN, Barber JP (2011) A meta-analysis of treatments for perinatal depression. Clin Psychol Rev 31:839-849. doi: 10.1016/j.cpr.2011. 03.009
35. Stowe ZN, Hostetter AL, Owens MJ et al (2003) The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations. J Clin Psychiatry 64:73-80
36. Stuart S, Couser G, Schilder K et al (1998) Postpartum anxiety and depression: onset and comorbidity in a community sample. J Nerv Ment Dis 186:420-424
37. Thase ME, Nierenberg AA, Vrijland P et al (2010) Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression. Int Clin Psychopharmacol 25:189-198. doi: 10.1097/YIC. 0b013e328330adb2
38. Turkmen S, Backstrom T, Wahlstrom G et al (2011) Tolerance to allopregnanolone with focus on the GABA-A receptor. Br J Pharmacol 162:311-327. doi: 10.1111/j.1476-5381.2010.01059.x
39. Wisner KL, Hanusa BH, Perel JM et al (2006) Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol 26:353-360. doi: 10.1097/01.jcp.0000227706.56870.dd
40. Wisner KL, Perel JM, Peindl KS et al (2001) Prevention of recurrent postpartum depression: a randomized clinical trial. J Clin Psychiatry 62:82-86
41. Yonkers KA, Lin H, Howell HB et al (2008) Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. J Clin Psychiatry 69:659-665
42. Yonkers KA, Vigod S, Ross LE (2011) Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet Gynecol 117:961-977. doi: 10.1097/AOG.0b013e31821187a7